Carotech Announces Tocotrienol Study on Cholesterol
The randomized, double-blind, placebo-controlled clinical trial is a collaboration between Ohio State University and the Government of Malaysia.
Researchers are conducting a yearlong trial on tocotrienol supplementation in subjects who have suffered ischemic stroke, according to tocotrienol supplier Carotech Inc. (Edison, NJ).
Carotech reports that the “Natural Tocotrienol Against Ischemic Stroke Event” trial will follow 210 volunteers taking palm tocotrienols for up to 12 months. Researchers will look for changes in platelet function and cholesterol as a result of tocotrienol supplementation.
The randomized, double-blind, placebo-controlled clinical trial is a collaboration between Ohio State University and the Government of Malaysia.
Visit Carotech online to stay updated on science involving tocotrienols.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.
